Department of Dermatology

GRK 2504: Preclinical evaluation of a combination of checkpoint blockade with dendritic cell vaccination against Merkel Cell Carcinoma and other virally induced cancers (B4) (GRK 2504 B4) GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504) Oct. 1, 2019 - Sept. 30, 2028 GRK 2504: LCMV as model for immune intervention by antigen targeting in chronic viral infections (B2) (GRK 2504 B2) GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504) Jan. 1, 2019 - Sept. 30, 2028 IZKF-N9 Engineered cells skin dis(601/DE: Dressing up and ready to move: Engineered immune cells for treatment of autoimmune skin diseases July 1, 2024 - June 30, 2027 IZKF-S4-Discover: DISCOVER April 1, 2025 - March 31, 2027 A100: Soluble CD83-induced pro-resolving macrophages strongly improve and accelerate wound healing processes July 1, 2023 - Dec. 31, 2026 IZKF-S2 Tame the Flame (M3): Interplay of cell trafficking and mechanics as a pathomechanism in immune-mediated inflammation “TAME THE FLAME” May 1, 2024 - April 30, 2026 ProDia - Protease Aktivität in Plasma-Vesikeln für die prädiktive Diagnostik von Tumorerkrankungen (DE-ProDia Medical Valley-Award) Nov. 1, 2023 - April 30, 2026 P146: Melanoma organoids as platform for testing oncological therapies July 1, 2024 - June 30, 2025 Systems medicine of melanoma and autoimmunity in the context of immunotherapy (MelAutim) Oct. 1, 2019 - Jan. 31, 2025 Bedeutung der Plasma-extrahierten extrazellulären Vesikel im Verlauf der spezifischen Immuntherapie gegenüber Insektengift Jan. 1, 2022 - Dec. 31, 2023